Oral solid dose at a turning point: Scaling for the next generation of therapies

Monday, September 28, 2026Miranda McLarenView original
Oral solid dose at a turning point: Scaling for the next generation of therapies
From patient-centric designs and sustainable changes to component shortages, anti-counterfeiting, and low-volume production, sponsors of OSD products are navigating a number of packaging trends and challenges.

Read the full article on the original site.

Read Full Article